Literature DB >> 8491242

On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation.

S Ohlman1, A Lindholm, H Hägglund, J Säwe, B D Kahan.   

Abstract

The intraindividual variability and circadian variation of oral cyclosporine (CsA) pharmacokinetics were studied over 24 h in 18 renal transplant recipients at steady state, and in 10 of the patients during a second 24 h period. The absolute percentage intraindividual difference in daytime AUC (0-12 h) ranged from 2% to 54% (mean 30%), and the corresponding variability in nighttime AUC (0-12 h) ranged from 5% to 80% (mean 34%). The pharmacokinetic variables t1/2, tmax and Cmax were more variable than the AUC (0-12 h) both during the day and at night. The evening trough level was significantly lower than the morning trough level; 185 ng.ml-1 versus 223 ng.ml-1. This, together with a significantly longer t1/2 in the night than the day, suggested circadian variability in the pharmacokinetics of CsA. In a separate retrospective study in 162 renal transplant recipients given CsA by constant intravenous infusion, repeated CsA blood concentration measurements at steady state showed lower concentrations during the day than the night, suggesting higher CsA clearance during daytime. It is concluded that CsA pharmacokinetics in renal transplant recipients, besides the well-known interindividual variability, also displays large intraindividual variability as well as circadian variation. Our findings further emphasize the necessity and difficulty of pharmacological monitoring in the clinical use of CsA in organ transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491242     DOI: 10.1007/BF00271369

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].

Authors:  M Ramon; D Morel; F Penouil; J Grellet; L Potaux; M C Saux; A Brachet-Liermain
Journal:  Therapie       Date:  1989 Sep-Oct       Impact factor: 2.070

2.  Studies of cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology.

Authors:  L D Bowers; D M Canafax; J Singh; R Seifedlin; R L Simmons; J S Najarian
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

3.  Diurnal variation in cyclosporine kinetics.

Authors:  R Venkataramanan; S Yang; G J Burckart; R J Ptachcinski; D H Van Thiel; T E Starzl
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

4.  Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

Authors:  S K Gupta; B Legg; L R Solomon; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

5.  Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.

Authors:  A Lindholm; S Henricsson
Journal:  Ther Drug Monit       Date:  1990-07       Impact factor: 3.681

Review 6.  Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy.

Authors:  B D Kahan; J Grevel
Journal:  Transplantation       Date:  1988-11       Impact factor: 4.939

7.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

8.  Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation.

Authors:  F J Frey; F F Horber; B M Frey
Journal:  Clin Pharmacol Ther       Date:  1988-01       Impact factor: 6.875

9.  Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.

Authors:  G Klintmalm; J Säwe; O Ringdén; C von Bahr; A Magnusson
Journal:  Transplantation       Date:  1985-02       Impact factor: 4.939

10.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245

View more
  5 in total

Review 1.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 2.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Chronopharmacokinetics of ciclosporin and tacrolimus.

Authors:  Massimo Baraldo; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Nano-bio-technology and sensing chips: new systems for detection in personalized therapies and cell biology.

Authors:  Sandro Carrara
Journal:  Sensors (Basel)       Date:  2010-01-12       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.